Medical Records, Reported Outcomes,
Surveys, & Questionnaires
Leverage Real-World Data
Patients are people. Weaving their experiences and perspectives into
biospecimen collection ties your analytical data to real-world outcomes,
yielding meaningful biomarkers that improve decision-making and accelerate
Our focus on constant and enriching patient engagement within our donor
community over time creates datasets relevant to researchers, patients, providers, regulators, and payers alike.
Data Collection Capabilities
We make it easy to include in your study design observational data collected in real-time from patient-reported outcome measures, electronic medical record information and history, custom patient surveys and questionnaires, wearable technologies, and long-term follow-up.
- Patient journey
- Patient preference
- Custom surveys and questionnaires
- Quality of life
- Burden of disease
- Impact on individuals
- Impact on families
- Wearable technologies
Medical Records & Laboratory Results
- Family history
- Treatment history
- Natural history
- Clinical genotypes and phenotypes
- Clinical testing
- Decision support tools
Sanguine provides you with access to highly annotated biospecimens prospectively collected from patients who routinely engage with us. We make it easy for you to obtain the real-world evidence you need to extract meaningful biomarkers from the data and increase the likelihood of success in clinical trials.
Access to more than 70,000 patients nationwide
Active, long-term patient relationships
Prospectively collected real-world data from patient surveys
Panoramic patient view harmonizes real-world evidence with biospecimen collection
Develop your own patient cohort or registry
Break team silos to increase cross-functional collaboration
Compliance & Quality Assured
Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval of all study protocols, specific study documentation, and study participant facing information. Both Advarra and WCG IRB are organized and operates in compliance with: FDA, OHRP, and International Conference on Harmonization (ICH).
Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.
Everything you need for biomarker development and validation
Explore our service offerings to cut timelines and costs, reduce variability, and translate your data into insights.